{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05095727",
            "orgStudyIdInfo": {
                "id": "mRNA-3745-P102"
            },
            "secondaryIdInfos": [
                {
                    "id": "2022-502963-39-00",
                    "type": "REGISTRY",
                    "domain": "Clinical Trials Information System (CTIS)"
                }
            ],
            "organization": {
                "fullName": "ModernaTX, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)",
            "officialTitle": "A Phase 1/2, Adaptive, Open-label, Single Ascending Dose to Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-3745 in Participants With Glycogen Storage Disease Type 1a (GSD1a), Followed by an Open-label Extension",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-mrna-in-adult-and-pediatric-participants-with-glycogen-storage-disease-type"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-06-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12-26",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-04",
            "studyFirstSubmitQcDate": "2021-10-14",
            "studyFirstPostDateStruct": {
                "date": "2021-10-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ModernaTX, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main goal of this trial is to evaluate the safety and tolerability of mRNA-3745 via intravenous (IV) administration in adult and pediatric participants with GSD1a.",
            "detailedDescription": "The study includes a single ascending dose (SAD) stage and a multiple ascending dose (MAD) stage. Participants enrolled in the MAD stage have the option to continue treatment in an open-label extension (OLE) period that will assess long-term safety and clinical activity of mRNA-3745."
        },
        "conditionsModule": {
            "conditions": [
                "Glycogen Storage Disease"
            ],
            "keywords": [
                "Glycogen storage disease type 1a",
                "GSD1a",
                "Von Gierke disease",
                "Glucose metabolism disorder",
                "Genetic disorder",
                "Autosomal recessive disorder",
                "messenger RNA",
                "mRNA",
                "Pediatric"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 45,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "SAD: mRNA-3745",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive a single intravenous (IV) dose of mRNA-3745 on Day 1 in an inpatient setting. Participants that are/have been enrolled in the study and receive an administration of mRNA-3745 may also enroll in one of the MAD cohorts. The first MAD dose must occur at least 21 days after the SAD dose.",
                    "interventionNames": [
                        "Drug: mRNA-3745"
                    ]
                },
                {
                    "label": "MAD: mRNA-3745",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple IV doses of mRNA-3745 in an inpatient setting. Participants will have the option to continue treatment in the OLE.",
                    "interventionNames": [
                        "Drug: mRNA-3745"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "mRNA-3745",
                    "description": "Sterile frozen liquid dispersion for injection",
                    "armGroupLabels": [
                        "MAD: mRNA-3745",
                        "SAD: mRNA-3745"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants With Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and TEAEs Leading to Treatment Discontinuation",
                    "timeFrame": "Day 1 up to approximately 3.5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of Participants Not Experiencing Hypoglycemia During Fasting Challenges",
                    "description": "Hypoglycemia is defined as blood glucose \\<60 milligrams (mg)/deciliter (dL) (3.3 millimoles \\[mmol\\]/liter \\[L\\]) and/or symptoms of hypoglycemia.",
                    "timeFrame": "Baseline through up to Week 32"
                },
                {
                    "measure": "Change From Baseline of Area Under the Effect Curve (AUEC) of Blood Glucose and Lactate During Fasting Challenges",
                    "timeFrame": "Baseline through up to Week 32"
                },
                {
                    "measure": "Change From Baseline in Time to Hypoglycemia During Fasting Challenges",
                    "timeFrame": "Baseline through up to Week 32"
                },
                {
                    "measure": "Change From Baseline in Maximum Effect (Emax) During Fasting Challenges",
                    "timeFrame": "Baseline through up to Week 32"
                },
                {
                    "measure": "SAD only: Maximum Observed Concentration (Cmax) of Messenger Ribonucleic Acid (mRNA) and Lipid Nanoparticle (LNP)",
                    "timeFrame": "Pre-infusion, during infusion, at the end of infusion (EOI) and post-infusion on Day 1 up to Week 52"
                },
                {
                    "measure": "SAD only: Area Under the Concentration-Time Curve From Time 0 to the Time of the Last Measurable Concentration (AUC0-t) of mRNA and LNP",
                    "timeFrame": "Pre-infusion, during infusion, at EOI and post-infusion on Day 1 up to Week 52"
                },
                {
                    "measure": "Change From Baseline in Metabolic Biomarkers of GSD1a",
                    "timeFrame": "Baseline through up to approximately 6.5 years"
                },
                {
                    "measure": "MAD only: Maximum Observed Concentration at Steady State (Cmax,ss) of mRNA and LNP",
                    "timeFrame": "Pre-infusion, during infusion, at the EOI and post-infusion on Day 1 up to Week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Documented GSD1a with confirmation by genetic testing\n* Documented history of a symptomatic hypoglycemic event with blood glucose \\<60 mg/dL (\\<3.3 mmol/L)\n* Absence of hospitalization for hypoglycemia in the 4 weeks prior to Screening\n\nExclusion Criteria:\n\n* Solid organ transplant\n* Received gene therapy for GSD1a\n* Presence of liver adenoma \\>5 centimeters (cm) in size\n* Diagnosis of type 1 or type 2 diabetes mellitus\n* Presence of liver adenoma with growth of \\>2 cm or \\>5 newly diagnosed liver adenomas, in the previous 2 years\n* Requirement for continuous feeds via gastrostomy or nasogastric tubes\n\nNote: Additional inclusion/exclusion criteria may apply, per protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Moderna Clinical Trials Support Center",
                    "role": "CONTACT",
                    "phone": "1-877-777-7187",
                    "email": "clinicaltrials@modernatx.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Connecticut Health Center",
                    "status": "RECRUITING",
                    "city": "Farmington",
                    "state": "Connecticut",
                    "zip": "06030-0001",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "860-679-6584",
                            "email": "shking@uchc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.71982,
                        "lon": -72.83204
                    }
                },
                {
                    "facility": "Boston Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "stephanie.lucia@childrens.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Duke University Medical Center",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27713",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "919-681-4026",
                            "email": "gretchen.nichting@duke.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "513-636-4507",
                            "email": "laurie.bailey@cchmc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "267-426-9915",
                            "email": "mitteerl@chop.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "The University of Texas Health Science Center at Houston",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030-1501",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "713-500-7098",
                            "email": "heather.saavedra@uth.tmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Baylor College of Medicine",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "713-610-2272",
                            "email": "ragini.sanyal@bcm.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "University of Utah",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84132-0001",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "801-587-3605",
                            "email": "carrie.bailey@hsc.utah.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Stollery Children's Hospital University of Alberta",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 2R7",
                    "country": "Canada",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "(780) 248-5611",
                            "email": "dory.sample@albertahealthservices.ca"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34035281",
                    "type": "BACKGROUND",
                    "citation": "Cao J, Choi M, Guadagnin E, Soty M, Silva M, Verzieux V, Weisser E, Markel A, Zhuo J, Liang S, Yin L, Frassetto A, Graham AR, Burke K, Ketova T, Mihai C, Zalinger Z, Levy B, Besin G, Wolfrom M, Tran B, Tunkey C, Owen E, Sarkis J, Dousis A, Presnyak V, Pepin C, Zheng W, Ci L, Hard M, Miracco E, Rice L, Nguyen V, Zimmer M, Rajarajacholan U, Finn PF, Mithieux G, Rajas F, Martini PGV, Giangrande PH. mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease. Nat Commun. 2021 May 25;12(1):3090. doi: 10.1038/s41467-021-23318-2."
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006008",
                    "term": "Glycogen Storage Disease"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004194",
                    "term": "Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000002239",
                    "term": "Carbohydrate Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "asFound": "Storage Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9114",
                    "name": "Glycogen Storage Disease",
                    "asFound": "Glycogen Storage Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9059",
                    "name": "Glycogen Storage Disease Type I",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5498",
                    "name": "Carbohydrate Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "T2560",
                    "name": "Glycogen Storage Disease Type 1A",
                    "asFound": "Glycogen Storage Disease Type 1a",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}